Df Dent & Co Cut Celgene (CELG) Stake as Stock Value Declined; Sempra Energy (SRE) Holder Colonial Trust Advisors Lowered Holding as Stock Value Declined

June 20, 2018 - By Dolores Ford

Sempra Energy (NYSE:SRE) Logo

Colonial Trust Advisors decreased its stake in Sempra Energy (SRE) by 16.83% based on its latest 2018Q1 regulatory filing with the SEC. Colonial Trust Advisors sold 3,682 shares as the company’s stock declined 3.94% with the market. The institutional investor held 18,202 shares of the natural gas distribution company at the end of 2018Q1, valued at $2.02 million, down from 21,884 at the end of the previous reported quarter. Colonial Trust Advisors who had been investing in Sempra Energy for a number of months, seems to be less bullish one the $29.92B market cap company. The stock increased 0.53% or $0.6 during the last trading session, reaching $113.27. About 1.95M shares traded. Sempra Energy (NYSE:SRE) has declined 8.17% since June 20, 2017 and is downtrending. It has underperformed by 20.74% the S&P500. Some Historical SRE News: 08/03/2018 – SEMPRA ENERGY – PUBLIC UTILITY COMMISSION OF TEXAS APPROVED ACQUISITION OF ENERGY FUTURE HOLDINGS, INCLUDING EFH’S ABOUT 80-PCT OWNERSHIP OF ONCOR; 28/03/2018 – SoCalGas Helps Fleet Owners Put New Near-Zero Emissions Natural Gas Trucks on the Road; 12/04/2018 – MEXICO’S IENOVA SAYS TO INVEST $130 MLN IN BAJA CALIFORNIA FUEL TERMINAL; 12/03/2018 – Sempra CEO to Retire; Company Expands Board by One; 12/04/2018 – SEMPRA ENERGY SRE.N – UNIT INFRAESTRUCTURA ENERGÉTICA TO DEVELOP LIQUID FUELS MARINE TERMINAL AT LA JOVITA ENERGY HUB IN ENSENADA, MEXICO; 10/04/2018 – SEMPRA ENERGY SAYS ON APRIL 9, BOARD APPOINTED TREVOR MIHALIK AS CFO SUCCEEDING JEFFERY MARTIN – SEC FILING; 12/03/2018 – Sempra Energy CEO Debra L. Reed to Retire Dec. 1, Step Down as CEO and Pres on May; 13/03/2018 – SoCalGas tells Calif. customers to watch natgas supplies due cold; 13/04/2018 – Moody’s Affirms lEnova’s Ratings and Changes Outlook to Stable; 07/05/2018 – SEMPRA IN TALKS WITH CUSTOMERS FOR LNG EXPORT FROM MEXICO

Df Dent & Co Inc decreased its stake in Celgene Corp (CELG) by 2.46% based on its latest 2018Q1 regulatory filing with the SEC. Df Dent & Co Inc sold 15,308 shares as the company’s stock declined 18.51% with the market. The institutional investor held 607,519 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $54.20 million, down from 622,827 at the end of the previous reported quarter. Df Dent & Co Inc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $57.58 billion market cap company. The stock increased 2.20% or $1.71 during the last trading session, reaching $79.44. About 6.71 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 32.65% since June 20, 2017 and is downtrending. It has underperformed by 45.22% the S&P500. Some Historical CELG News: 04/05/2018 – Celgene 1Q Rev $3.54B; 09/04/2018 – FierceBiotech: According to people “briefed on its plans”, and talking to FT journos, Celgene is “hunting for acquisition; 10/04/2018 – Oncolytics Biotech: Combination Therapy With REOLYSIN(R), Keytruda(R) and/or anti-CD73 Immunotherapy Led to Rejection of Pre-Established Tumors; 16/05/2018 – G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting; 08/05/2018 – ONCOSEC EXPANDS RELATIONSHIP WITH MERCK, ANNOUNCES CLINICAL COLLABORATION TO EVALUATE COMBINATION OF IMMUNOPULSE IL-12 AND KEYTRUDA FOR TRIPLE NEGATIVE BREAST CANCER; 02/05/2018 – The Klein Law Firm Announces a Class Action Commenced on Behalf of Celgene Corporation Shareholders and a Lead Plaintiff; 27/03/2018 – BRISTOL-MYERS: FDA ACCEPTS APPLICATION FOR OPDIVO PLUS YERVOY; 09/04/2018 – STAT Plus: With positive Keytruda data, Merck scrambles the market for lung cancer immunotherapies; 16/04/2018 – OPDIVO 1-YEAR PROGRESSION-FREE SURVIVAL RATE `SUPERIOR BENEFIT’; 21/05/2018 – Top 3 today – #1 BD chief George Golumbeski is the latest top exec to exit Celgene during management overhaul $CELG (with interview)

Investors sentiment decreased to 0.79 in Q1 2018. Its down 0.04, from 0.83 in 2017Q4. It worsened, as 120 investors sold CELG shares while 470 reduced holdings. 106 funds opened positions while 363 raised stakes. 513.18 million shares or 8.59% less from 561.38 million shares in 2017Q4 were reported. Grandfield Dodd Limited Liability Corporation has 0.02% invested in Celgene Corporation (NASDAQ:CELG). Bp Public Limited has 89,600 shares for 0.29% of their portfolio. Janney Montgomery Scott Llc holds 213,974 shares. Cypress Capital Gru reported 35,197 shares stake. First Heartland Consultants holds 4,579 shares. Duff & Phelps Investment Management Co stated it has 8,380 shares. Aperio Group Ltd holds 421,524 shares. Comml Bank Pictet And Cie (Asia) Limited stated it has 14,035 shares. Fmr Ltd reported 7.11M shares or 0.08% of all its holdings. Cs Mckee Limited Partnership invested in 183,350 shares or 1.28% of the stock. Garrison Bradford And Assocs has 4.99% invested in Celgene Corporation (NASDAQ:CELG) for 65,750 shares. Bradley Foster & Sargent Ct reported 0.18% stake. Manchester Capital Management Limited, a Vermont-based fund reported 1,226 shares. Jpmorgan Chase & invested in 5.41 million shares. Pictet Financial Bank Tru Limited reported 41,810 shares or 1.33% of all its holdings.

Df Dent & Co Inc, which manages about $4.32 billion US Long portfolio, upped its stake in Carriage Services Inc. (NYSE:CSV) by 24,355 shares to 115,596 shares, valued at $3.20 million in 2018Q1, according to the filing. It also increased its holding in Lyondellbasell Industries N V (NYSE:LYB) by 4,522 shares in the quarter, for a total of 9,830 shares, and has risen its stake in Monro Inc (NASDAQ:MNRO).

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Goldman bearish on Celgene” on May 25, 2018, also Fool.com with their article: “3 Top Biotech Stocks to Buy Right Now” published on June 18, 2018, Seekingalpha.com published: “Best And Worst Performing Nasdaq 100 Stocks Of 2018” on May 25, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Seekingalpha.com and their article: “Is Celgene’s Stock A Buy The Dip Opportunity?” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “Tandem Diabetes Care Has Run Up A Lot – Cramer’s Lightning Round (6/15/18)” with publication date: June 18, 2018.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36 billion for 10.62 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 21 have Buy rating, 1 Sell and 13 Hold. Therefore 60% are positive. Celgene Corporation had 151 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Neutral” rating by BTIG Research on Wednesday, June 1. The firm has “Buy” rating given on Thursday, October 5 by BMO Capital Markets. The rating was upgraded by Atlantic Securities to “Overweight” on Friday, December 8. The stock of Celgene Corporation (NASDAQ:CELG) earned “Underweight” rating by Morgan Stanley on Monday, October 23. The stock has “Buy” rating by Stifel Nicolaus on Friday, July 15. As per Friday, October 20, the company rating was maintained by Barclays Capital. As per Tuesday, June 6, the company rating was maintained by Canaccord Genuity. The rating was maintained by SunTrust on Friday, October 20 with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Standpoint Research on Monday, June 18. Guggenheim initiated it with “Buy” rating and $160.0 target in Monday, October 23 report.

Since February 8, 2018, it had 2 buys, and 5 insider sales for $5.91 million activity. On Friday, February 23 MARIO ERNEST sold $1.26M worth of Celgene Corporation (NASDAQ:CELG) or 13,370 shares. On Thursday, February 8 Alles Mark J bought $299,594 worth of Celgene Corporation (NASDAQ:CELG) or 3,260 shares. $851,093 worth of Celgene Corporation (NASDAQ:CELG) was sold by LOUGHLIN JAMES J. CASEY MICHAEL D sold $1.02 million worth of Celgene Corporation (NASDAQ:CELG) on Thursday, June 7.

Among 11 analysts covering Sempra Energy (NYSE:SRE), 6 have Buy rating, 0 Sell and 5 Hold. Therefore 55% are positive. Sempra Energy had 27 analyst reports since September 15, 2015 according to SRatingsIntel. The firm has “Buy” rating by Guggenheim given on Sunday, April 22. Bank of America downgraded Sempra Energy (NYSE:SRE) rating on Friday, December 22. Bank of America has “Hold” rating and $112.0 target. The stock of Sempra Energy (NYSE:SRE) has “Buy” rating given on Sunday, November 5 by RBC Capital Markets. As per Thursday, June 8, the company rating was downgraded by Barclays Capital. Wells Fargo maintained it with “Outperform” rating and $120 target in Wednesday, February 28 report. The rating was maintained by JP Morgan on Tuesday, March 6 with “Neutral”. The rating was maintained by JP Morgan with “Neutral” on Monday, June 4. The firm has “Buy” rating by RBC Capital Markets given on Sunday, October 1. The firm earned “Neutral” rating on Tuesday, June 12 by Bank of America. BMO Capital Markets maintained it with “Hold” rating and $11800 target in Friday, August 4 report.

Analysts await Sempra Energy (NYSE:SRE) to report earnings on August, 3. They expect $1.22 earnings per share, up 10.91% or $0.12 from last year’s $1.1 per share. SRE’s profit will be $322.25 million for 23.21 P/E if the $1.22 EPS becomes a reality. After $1.43 actual earnings per share reported by Sempra Energy for the previous quarter, Wall Street now forecasts -14.69% negative EPS growth.

Since April 5, 2018, it had 0 insider buys, and 3 sales for $6.14 million activity. OUCHI WILLIAM G sold $201,006 worth of Sempra Energy (NYSE:SRE) on Wednesday, May 9. 3,948 shares were sold by ROWLAND G JOYCE, worth $433,530.

Investors sentiment decreased to 1 in 2018 Q1. Its down 0.27, from 1.27 in 2017Q4. It fall, as 54 investors sold SRE shares while 178 reduced holdings. 63 funds opened positions while 170 raised stakes. 225.19 million shares or 17.16% more from 192.21 million shares in 2017Q4 were reported. Rnc Mgmt Limited Co reported 2,726 shares. Perigon Wealth Mngmt reported 4,566 shares. Raymond James Financial Services Advsrs, Florida-based fund reported 18,854 shares. Bridges Invest Mgmt owns 6,675 shares. Fort Washington Inv Advsr Oh holds 19,117 shares or 0.02% of its portfolio. X Mgmt Com Ltd Liability Com invested 0.02% of its portfolio in Sempra Energy (NYSE:SRE). Price T Rowe Associates Md owns 0.43% invested in Sempra Energy (NYSE:SRE) for 24.59 million shares. Duff Phelps Invest Mgmt holds 992,610 shares. Thompson Siegel And Walmsley Limited Liability Corp has invested 0% in Sempra Energy (NYSE:SRE). Reilly Advisors Ltd Liability Co reported 7,306 shares or 0.11% of all its holdings. Cibc Markets Corp reported 0.09% in Sempra Energy (NYSE:SRE). Bessemer Gru Inc has 0% invested in Sempra Energy (NYSE:SRE). Pitcairn Company holds 0.02% or 1,998 shares. Everence Cap Incorporated holds 0.14% in Sempra Energy (NYSE:SRE) or 5,733 shares. Dupont Mgmt Corp holds 0.04% or 13,633 shares.

More important recent Sempra Energy (NYSE:SRE) news were published by: Benzinga.com which released: “A Look Back At What’s Happened To Each Sector Through The First Half Of 2018 (Part 2)” on June 19, 2018, also Benzinga.com published article titled: “Wells Fargo Downgrades Sempra Energy After Monday’s Spike On Activist Involvement”, Seekingalpha.com published: “Low Energy MLPs” on June 17, 2018. More interesting news about Sempra Energy (NYSE:SRE) was released by: Seekingalpha.com and their article: “California recommends increasing gas storage at Aliso Canyon” with publication date: June 19, 2018.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>